I track companies that are relatively cheap and would fall in a sector that are performing well above the S&P index. Another factor that I consider would be the potential for future growth. Take, for example, Synergy Pharmaceuticals Inc. (NASDAQ:SGYP). For those of you who have never heard of Synergy, it is a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies.
